ASCENT Trial: TRODELVY (sacituzumab govitecan) in mTNBC Breast 13 Mins Read2 ASCENT Trial and Trodelvy (Sacituzumab Govitecan) Improves Progression Free Survival in Metastatic Triple Negative Breast (mTNBC) 5 Key Stats for…
